Challenges of Joe Biden’s tenure
Miguel A. Temprano, CEO of Orfeo Capital, intervenes in a program presented by Marta Iser of the Negocios TV chain to analyze what to expect, especial...
18 January 2021[+] Read More
Investment opportunities
Miguel Ángel Temprano, CEO of Orfeo Capital, speaks on Negocios Tv to explain his point of view on the consequences of the aid announced by President...
15 January 2021[+] Read More
Investment Outlook and Opportunities for 2021: The Year of Recovery
Miguel Ángel Temprano, CEO of Orfeo Capital, believes that “in the best of scenarios, we should not expect a recovery, understanding as such to rec...
13 January 2021[+] Read More
A balance of 2020 and we are already looking towards 2021
Miguel Ángel Temprano, Investment Director of Orfeo Capital, analyzes the incidents widely publicized around the world that occurred in the American ...
07 January 2021[+] Read More
Analysis of the repercussions on the markets of the incidents that occurred
Miguel Ángel Temprano, CEO of Orfeo Capital, intervenes in the Market Closure program, directed by Fernando Latienda to analyze the repercussions on ...
07 January 2021[+] Read More
“Republicans want Trump to disappear from the party”
Miguel Ángel Temprano, Investment Director of Orfeo Capital, analyzes the status of vaccines and the implications that their distribution may have on...
30 December 2020[+] Read More
Until summer let’s not wait for a quiet world
Miguel Angel Temprano, CEO and Chief Investment Director of Orfeo Capital participates in the talk on the forecasts for the end of the year and 2021. ...
02 December 2020[+] Read More
Record in public debt in September
Record in public debt in September, Spain receives another 4,000 million euros from the European fund for employment assistance. with Miguel Ángel Te...
18 November 2020[+] Read More
“This looks more like a statement for stocks to go up than anything else. Nothing has been published yet in scientific journals.”
With Miguel Ángel Temprano, CEO of Orfeo Capital, we will analyze the context of the markets, how the announcement of the Pfizer and Moderna vaccine ...
11 November 2020[+] Read More